n-methyl-3,4-methylenedioxyamphetamine has been researched along with Pain in 8 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
Pain: An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "When caffeine was administered prior to MDMA, a potentiation of locomotor activity was observed, which consisted in an increase in maximal values and in a prolonged time of activity." | 1.33 | Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug. ( Camarasa, J; Escubedo, E; Pubill, D, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morley-Fletcher, S | 1 |
| Bianchi, M | 1 |
| Gerra, G | 1 |
| Laviola, G | 1 |
| Camarasa, J | 1 |
| Pubill, D | 1 |
| Escubedo, E | 1 |
| McCann, UD | 1 |
| Ridenour, A | 1 |
| Shaham, Y | 1 |
| Ricaurte, GA | 1 |
| Williams, A | 1 |
| Segal, O | 1 |
| Andrews, B | 1 |
| Morley, KC | 1 |
| McGregor, IS | 1 |
| Crisp, T | 1 |
| Stafinsky, JL | 1 |
| Boja, JW | 1 |
| Schechter, MD | 1 |
| Whitaker-Azmitia, PM | 1 |
| Nencini, P | 1 |
| Woolverton, WL | 1 |
| Seiden, LS | 1 |
1 trial available for n-methyl-3,4-methylenedioxyamphetamine and Pain
| Article | Year |
|---|---|
Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Analysis of Variance; Female; Homovanillic Acid; Humans; Hydro | 1994 |
7 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Pain
| Article | Year |
|---|---|
Acute and carryover effects in mice of MDMA ("ecstasy") administration during periadolescence.
Topics: Aging; Animals; Behavior, Animal; Female; Hallucinogens; Hypothalamus; Locomotion; Male; Mice; N-Met | 2002 |
Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug.
Topics: Analgesics; Animals; Body Temperature; Brain; Caffeine; Central Nervous System Stimulants; Disease M | 2006 |
Short gastric artery perforation after use of 'ecstasy'.
Topics: Adult; Gastrointestinal Hemorrhage; Hallucinogens; Humans; Ligation; Male; N-Methyl-3,4-methylenedio | 1998 |
(+/-)-3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases social interaction in rats.
Topics: Animals; Anxiety; Cats; Electroshock; Environment; Hallucinogens; Interpersonal Relations; Male; Mot | 2000 |
The antinociceptive effects of 3,4-methylenedioxymethamphetamine (MDMA) in the rat.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Analgesics; Animals; Dose-Response Relationship, Drug; | 1989 |
Depression to ecstasy. The Neuropharmacology of Serotonin sponsored by the New York Academy of Sciences, New York, NY, USA, July 10-13, 1989.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain Mapping; Depression; Humans; Mental Disorders; Migrain | 1989 |
Enhancement of morphine-induced analgesia after repeated injections of methylenedioxymethamphetamine.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Analgesia; Animals; Body Weight; Catecholamines; Centra | 1988 |